In women with moderate to severe endometriosis, does treatment with anti-inflammatory cytokine modulators (such as TNF-α inhibitors) compared with standard hormonal therapy or placebo result in greater regression of endometriotic lesions and symptom improvement?
article
OA: green
CC0
Abstract
Currently, there is limited clinical evidence regarding the effectiveness of TNF-α inhibitors compared to standard hormonal therapy or placebo in reducing endometriotic lesions and symptoms. More research is needed to establish their role in endometriosis treatment.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK